Kimberly Guajardo, APRN
Nurse Practitioner · Live Oak, TXNPI 1639704257
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $4,811 with a category attached, or 62.4%. Intrinsic Therapeutics accounts for 62.8% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $3,117, 4.9 times the $633 reported in 2021. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $114.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intrinsic Therapeutics$3K
- Medtronic$817
- Si-bone, Inc.$760
- Boston Scientific$102
- Nalu Medical, Inc.$30
- Relievant Medsystems, Inc.$23
- plus $60 from 3 others
What the payments were for
- Consulting fees$3,00062%
- Travel & lodging$91719%
- Food & beverage$89419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intrinsic Therapeutics | 15 | $3,019 |
| Medtronic | 12 | $817 |
| Si-bone, Inc. | 7 | $760 |
| Boston Scientific | 3 | $102 |
| Nalu Medical, Inc. | 1 | $30 |
| Relievant Medsystems, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Smith+Nephew | 1 | $20 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$6,000
- iFuse Implant$580
- O-ARM$226
- CD HORIZON$103
How this compares
$4,811 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 113 | $1,738 |
| Tizanidine Hcl | 46 | $531 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $452 |
| Gabapentin | 39 | $378 |
| Cyclobenzaprine Hcl | 26 | $183 |
| Diazepam | 29 | $133 |
| Ciprofloxacin Hcl | 11 | $58 |
| Meloxicam | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Live Oak
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.